# 2026-07421: FDA Seeks Comments on Prescription Drug Import Data Collection

2026-07421, Agency Information Collection Activities; Proposed Collection; Comment Request; Importation of Prescription Drugs, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-04-16, effective Either electronic or written comments on the collection of information must be submitted by June 15, 2026.; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-07421
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-07421
- Title: Agency Information Collection Activities; Proposed Collection; Comment Request; Importation of Prescription Drugs
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 20462
- Published: 2026-04-16
- Effective: Either electronic or written comments on the collection of information must be submitted by June 15, 2026.
- Comments close: 2026-06-15
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

FDA Seeks Comments on Prescription Drug Import Data Collection

## Summary

The FDA wants your thoughts on how they collect info about importing prescription drugs. This affects drug companies and anyone involved in bringing meds into the U.S. You’ve got until June 15, 2026, to share your comments—no cost to join, just your voice! The goal? Make sure the rules are clear and easy to follow.

## Abstract

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection provisions related to FDA's regulation on importation of prescription drugs.

## Effects PRIA read

- Recordkeeping Burden for Importation Sponsors: cost, high. If you are a Section 804 Importation Program (SIP) Sponsor, an importer (pharmacist or wholesale distributor), or a drug manufacturer, FDA estimates the paperwork burden at 100 total annual records and 6,040 hours per year. Specifically, Subpart B is estimated at 60 records at 72 hours each (4,320…
- Section 804 Aims to Lower Drug Costs: benefit, low. The purpose of section 804 of the Federal Food, Drug, and Cosmetic Act is to reduce the cost of covered prescription products to American consumers without imposing additional risks to public health and safety. The regulations in 21 CFR part 251 set procedures for SIP Sponsors to submit plans for t…

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-07421 on federalregister.gov](https://www.federalregister.gov/documents/2026/04/16/2026-07421/agency-information-collection-activities-proposed-collection-comment-request-importation-of)
- [2026-07421 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-04-16/pdf/2026-07421.pdf)

## Related
- [Previous: 2026-07420, Publishing.com, LLC, Christian Mikkelsen, and Rasmus Mikkelsen; Analysis of Pro…](https://policyrisk.com/federal-register/2026-07420)
- [Next: 2026-07422, Determination of Regulatory Review Period for Purposes of Patent Extension; UNL…](https://policyrisk.com/federal-register/2026-07422)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-07421 (as of 2026-06-08).
